Combination and sequential therapy for postmenopausal osteoporosis: recent advances and clinical practice
Combined and sequential therapies represent promising approaches for improving the management of PMO by maximizing therapeutic efficacy while minimizing adverse effects and the potential roles of genomics, bone metabolism biomarkers, and artificial intelligence in supporting personalized treatment strategies are discussed.